I'm always working toward health equity. My goal is to bring the same innovative approaches and great outcomes to all patients.
Where I see patients (1)
Selected research
-
Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities.
Blood advances
-
Cyclophosphamide and thiotepa increases risk of transplant-associated thrombotic microangiopathy.
Transplantation and cellular therapy
-
Clinical trial recruitment of people who speak languages other than english: a children's oncology group report.
JNCI cancer spectrum
Clinical trials
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children,...
We will estimate the cumulative incidence of severe GVHD at 1-year post-HCT and corresponding 95% confidence interval among enrolled and eligible patients randomly assigned to either HAPLO or MUD arms who actually undergo HCT.
Recruiting
More about this studyContact me
Translation, please
We have interpreters for Cantonese, Mandarin, Spanish, Russian, American Sign Language and more.
Request an interpreter![](/-/media/project/ucsf/ucsf-bch/images/by-your-side-moment/duck/bys_footer_duck-playful-2x.jpg?rev=1202c0da42924c018f0aa29874303fe9&hash=EA0B683476A8641ABA67D2564291622E)